Edwards Lifesciences Capital Expenditure Trend

EW -- USA Stock  

USD 168.35  2.88  1.74%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Capital Expenditure of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived; physical & intangible assets that are used in the normal conduct of business to produce goods and services and are not intended for resale. Includes cash inflows/outflows to pay for construction of self-constructed assets & software.
Capital Expenditure10 Years Trend
Slightly volatile
 Capital Expenditure 

Edwards Lifesciences Regression Statistics

Arithmetic Mean(99,419,737)
Geometric Mean 89,512,682
Coefficient Of Variation(46.86)
Mean Deviation 37,186,404
Standard Deviation 46,586,988
Range 138,600,000
R Value(0.90)
R Squared 0.82
Significance 0.00005562

Edwards Lifesciences Capital Expenditure Over Time

2016-12-31 (176,100,000) 
2017-12-31 (176,100,000) 
2018-12-31 (146,736,842) 

Other Fundumenentals of Edwards Lifesciences

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Edwards Lifesciences Fundamental Drivers

Edwards Lifesciences Corporation Fundamental Market Drivers

Short Percent Of Float1.27%
Forward Price Earnings29.27
Shares Short Prior Month2.66M
Average Daily Volume Last 10 Day1.1M
Average Daily Volume In Three Month1.15M
Date Short InterestAugust 31, 2018
Fifty Day Average142.32
Two Hundred Day Average141.80

Edwards Lifesciences Upcoming Events

Edwards Lifesciences Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Search macroaxis.com